JMP Securities Keeps Their Buy Rating on LPL Financial (LPLA)
JMP Securities analyst Devin Ryan reiterated a Buy rating on LPL Financial (LPLA – Research Report) today and set a price target of $435.00.
Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering
Spartan Capital Securities, LLC, a leading full-service investment banking and financial advisory firm, is proud to announce its role as sole placement agent for Virpax Pharmaceuticals, Inc. (Nasdaq: ...